Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GlycoMimetics Inc | Sandell D Scott | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.12 per share. | 25 Jan 2023 | 1,648,908 | 2,730,334 (6%) | 3% | 3.1 | 5,142,614 | Common Stock |
| GlycoMimetics Inc | Sandell D Scott | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.12 per share. | 25 Jan 2023 | 1,351,092 | 2,237,196 (5%) | 3% | 3.1 | 4,213,786 | Common Stock |
| QXO Inc | Mark Meller | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Jan 2023 | 800,000 | 0 (0%) | 17% | 0 | Common Stock, par value $0.00001 per share | |
| QXO Inc | Mark Meller | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Jan 2023 | 800,000 | 800,000 (17%) | 17% | 0 | Common Stock, par value $0.00001 per share | |
| Alcoa Corp | Roy Christopher Harvey | Director, President, CEO & Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 526,853 | 1,206,324 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| GlycoMimetics Inc | Sandell D Scott | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.26 per share. | 25 Jan 2023 | 358,371 | 4,379,242 (10%) | 0% | 3.3 | 1,169,687 | Common Stock |
| Archer-Daniels-Midland | Juan R. Luciano | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 349,488 | 762,330 (0%) | 0% | 0 | Common Stock | |
| APA | John J. Christmann | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 336,486 | 604,957 | - | - | Restricted Stock / Units | |
| SkyAI Inc | Robert M. Hayes | Director, Chief Executive Officer | 25 Jan 2023 | 330,000 | 330,000 | - | - | Stock Option (right to buy) | ||
| GlycoMimetics Inc | Sandell D Scott | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 3.26 per share. | 25 Jan 2023 | 293,645 | 3,588,288 (8%) | 0% | 3.3 | 958,428 | Common Stock |
| WisdomTree Inc | Jonathan L. Steinberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 276,240 | 276,240 | - | - | Performance Based Restricted Stock Units | |
| Evolus Inc | David Moatazedi | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 257,009 | 257,009 | - | - | Stock Option (Right to Buy) | |
| Alcoa Corp | Roy Christopher Harvey | Director, President, CEO & Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.19 per share. | 25 Jan 2023 | 226,184 | 980,140 (0%) | 0% | 52.2 | 11,804,543 | Common Stock, par value $0.01 per share |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 192.33 per share. | 25 Jan 2023 | 219,829 | 2,819,338 (4%) | 0% | 192.3 | 42,279,712 | Common Stock |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 219,829 | 165,133 | - | - | Employee Stock Option | |
| Pliant Therapeutics Inc | Bernard Coulie | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 206,300 | 206,300 | - | - | Stock Option (right to buy) | |
| Archer Aviation Inc (Class A) | Brett Adcock | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.57 per share. | 25 Jan 2023 | 200,000 | 0 | - | 2.6 | 514,060 | Class A Common Stock |
| Archer Aviation Inc (Class A) | Brett Adcock | Ten Percent Owner | 25 Jan 2023 | 200,000 | 23,198,487 | - | - | Class B Common Stock | ||
| Archer Aviation Inc (Class A) | Brett Adcock | Ten Percent Owner | 25 Jan 2023 | 200,000 | 200,000 | - | - | Class A Common Stock | ||
| Evolus Inc | David Moatazedi | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 187,927 | 679,888 (2%) | 0% | 0 | Common Stock | |
| Ball Corp | Daniel W. Fisher | Director, President & C.E.O. | 25 Jan 2023 | 171,091 | 171,091 | - | - | Stock Option (Right to Buy) | ||
| WisdomTree Inc | R. Jarrett | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 168,686 | 168,686 | - | - | Performance Based Restricted Stock Units | |
| APA | John J. Christmann | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 168,243 | 436,714 | - | - | Restricted Stock / Units | |
| APA | John J. Christmann | Director, CEO and President | Sale or transfer of securities back to the company at price $ 46.68 per share. | 25 Jan 2023 | 168,243 | 511,992 (0%) | 0% | 46.7 | 7,853,583 | Common Stock |
| APA | John J. Christmann | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 168,243 | 680,235 (0%) | 0% | 0 | Common Stock | |
| Shattuck Labs Inc | Taylor H. Schreiber | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 165,050 | 165,050 | - | - | Stock Option (Right to Buy) | |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 191.61 per share. | 25 Jan 2023 | 159,074 | 2,844,728 (4%) | 0% | 191.6 | 30,480,169 | Common Stock |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 159,074 | 6,059 | - | - | Employee Stock Option | |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 192.18 per share. | 25 Jan 2023 | 157,955 | 2,695,649 (4%) | 0% | 192.2 | 30,355,792 | Common Stock |
| Pliant Therapeutics Inc | Bernard Coulie | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 146,300 | 240,112 | - | 0 | Common Stock | |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 145,526 | 384,962 | - | - | Employee Stock Option | |
| APA | Stephen J. Riney | Executive Vice Pres & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 143,899 | 267,385 | - | - | Restricted Stock / Units | |
| Yelp Inc | Jeremy Stoppelman | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 141,667 | 643,403 (0%) | 0% | 0 | Common Stock | |
| Marchex Inc (Class B) | Ryan Polley | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 140,000 | 140,000 | - | - | Employee Stock Option (right to buy) | |
| SkyAI Inc | Soren Bo Christiansen | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Jan 2023 | 135,000 | 135,000 | - | - | Stock Option (right to buy) | |
| E.W. Scripps Co. (Class A) | Mary McCabe Peirce | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Jan 2023 | 124,637 | 90,196 (0%) | 0% | 0 | Common Voting Shares, $.01 par value per share | |
| Alcoa Corp | William F. Oplinger | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 105,385 | 239,120 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Achieve Life Sciences Inc | John Bencich | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc | John Bencich | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 100,000 | 100,000 | - | - | Performance Restricted Stock Unit (PRSU) | |
| SkyAI Inc | Alan R. Blackman | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Jan 2023 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| Regions Financial | C. Lusco Matthew | SEVP & CRO | Sale of securities on an exchange or to another person at price $ 22.83 per share. | 25 Jan 2023 | 100,000 | 77,843 (0%) | 0% | 22.8 | 2,282,760 | Common Stock |
| APA | David A. Pursell | Exec. Vice Pres - Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 97,743 | 182,273 | - | - | Restricted Stock / Units | |
| Evolus Inc | Rui Avelar | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 97,642 | 350,831 (1%) | 0% | 0 | Common Stock | |
| LSB Ind Inc | Mark T. Behrman | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 12.34 per share. | 25 Jan 2023 | 95,462 | 1,688,998 (5%) | 0% | 12.3 | 1,178,001 | Common Stock |
| Archer-Daniels-Midland | Gregory A. Morris | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 93,198 | 324,652 (0%) | 0% | 0 | Common Stock | |
| Archer-Daniels-Midland | Vincent F. Macciocchi | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 93,198 | 328,030 (0%) | 0% | 0 | Common Stock | |
| Chevron | Michael K. Wirth | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 92,800 | 92,800 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Allbirds Inc (Class A) | Joseph Zwillinger | Director, Co-Chief Executive Officer, Ten Percent Owner | 25 Jan 2023 | 92,643 | 10,991,500 | - | - | Class B Common Stock | ||
| Allbirds Inc (Class A) | Joseph Zwillinger | Director, Co-Chief Executive Officer, Ten Percent Owner | 25 Jan 2023 | 92,643 | 0 | - | 2.8 | 257,548 | Class A Common Stock | |
| Allbirds Inc (Class A) | Joseph Zwillinger | Director, Co-Chief Executive Officer, Ten Percent Owner | 25 Jan 2023 | 92,643 | 92,643 | - | 0 | Class A Common Stock | ||
| APA | P. Anthony Lannie | Exec. Vice Pres & Gen Counsel | 25 Jan 2023 | 90,574 | 164,141 | - | - | Restricted Stock / Units | ||
| SkyAI Inc | Paul K. Danner | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Jan 2023 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
| SkyAI Inc | Timothy J. Ruemler | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Jan 2023 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
| SkyAI Inc | Brenda Baird Simpson | Director | 25 Jan 2023 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | ||
| SkyAI Inc | Jason L. Monroe | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Jan 2023 | 90,000 | 90,000 | - | - | Stock Option (right to buy) | |
| Herc Holdings Inc | Carl C. Icahn | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 150.98 per share. | 25 Jan 2023 | 88,816 | 3,357,933 (11%) | 0% | 151.0 | 13,409,440 | Shares |
| Evolus Inc | Rui Avelar | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 85,670 | 85,670 | - | - | Stock Option (Right to Buy) | |
| Evolus Inc | Sandra Beaver | Chief Financial Officer | 25 Jan 2023 | 85,670 | 85,670 | - | - | Stock Option (Right to Buy) | ||
| FTC Solar Inc | Tamara Mullings | Director | 25 Jan 2023 | 84,805 | 166,581 | - | 0 | Common Stock | ||
| Matson Inc | Matthew J. Cox | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 84,225 | 309,440 (0%) | 0% | 0 | Common Stock | |
| SPS Commerce Inc | Archie C. Black | Director, CEO | 25 Jan 2023 | 80,852 | 137,124 (0%) | 0% | 0 | Common Stock | ||
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | 25 Jan 2023 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | ||
| Pliant Therapeutics Inc | Hans P. Hull | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 76,200 | 76,200 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 76,200 | 76,200 | - | - | Stock Option (right to buy) | |
| Archrock Inc | D. Bradley Childers | Director, PRESIDENT AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.38 per share. | 25 Jan 2023 | 76,151 | 1,768,136 (1%) | 0% | 9.4 | 714,296 | Common Stock |
| Applied Dna Sciences Inc | Sanford R. Simon | Director | 25 Jan 2023 | 75,099 | 75,099 | - | - | Incentive Stock Option (right to buy) | ||
| Applied Dna Sciences Inc | Yacov A. Shamash | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 75,099 | 75,099 | - | - | Incentive Stock Option (right to buy) | |
| Applied Dna Sciences Inc | Robert B. Catell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 75,099 | 75,099 | - | - | Incentive Stock Option (right to buy) | |
| Applied Dna Sciences Inc | Joseph D. Ceccoli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 75,099 | 75,099 | - | - | Incentive Stock Option (right to buy) | |
| Applied Dna Sciences Inc | Scott L. Anchin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 75,099 | 75,099 | - | - | Incentive Stock Option (right to buy) | |
| Applied Dna Sciences Inc | Elizabeth M. Schmalz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 75,099 | 75,099 | - | - | Incentive Stock Option (right to buy) | |
| Bank of America | Andrew M. Sieg | Pres, Merrill Wealth Mgmt | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 75,000 | 0 | - | - | Restricted Stock Units | |
| Bank of America | Andrew M. Sieg | Pres, Merrill Wealth Mgmt | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 75,000 | 388,886 (0%) | 0% | - | Common Stock | |
| Bank of America | Alastair Borthwick | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 75,000 | 0 | - | - | Restricted Stock Units | |
| Bank of America | Alastair Borthwick | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 75,000 | 301,228 (0%) | 0% | - | Common Stock | |
| Bank of America | James P. DeMare | President, Global Markets | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 75,000 | 215,807 (0%) | 0% | - | Common Stock | |
| Bank of America | James P. DeMare | President, Global Markets | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 75,000 | 0 | - | - | Restricted Stock Units | |
| Bank of America | Matthew M. Koder | Pres, Gl Corp & Invest Banking | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 75,000 | 439,202 (0%) | 0% | - | Common Stock | |
| Bank of America | Matthew M. Koder | Pres, Gl Corp & Invest Banking | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 75,000 | 0 | - | - | Restricted Stock Units | |
| Achieve Life Sciences Inc | Richard Alistair Balfour Stewart | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 75,000 | 75,000 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc | Richard Alistair Balfour Stewart | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 75,000 | 75,000 | - | - | Performance Restricted Stock Unit (PRSU) | |
| Archer-Daniels-Midland | D. Cameron Findlay | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 73,394 | 358,381 (0%) | 0% | 0 | Common Stock | |
| APA | Stephen J. Riney | Executive Vice Pres & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 71,948 | 91,376 (0%) | 0% | 0 | Common Stock | |
| APA | Stephen J. Riney | Executive Vice Pres & CFO | Sale or transfer of securities back to the company at price $ 46.68 per share. | 25 Jan 2023 | 71,948 | 19,428 (0%) | 0% | 46.7 | 3,358,533 | Common Stock |
| APA | Stephen J. Riney | Executive Vice Pres & CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 71,948 | 195,437 | - | - | Restricted Stock / Units | |
| Yelp Inc | Joseph R. Nachman | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 70,834 | 332,435 (0%) | 0% | 0 | Common Stock | |
| Archer-Daniels-Midland | Christopher M. Cuddy | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 69,898 | 322,893 (0%) | 0% | 0 | Common Stock | |
| Shattuck Labs Inc | Andrew R. Neill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 69,850 | 69,850 | - | - | Stock Option (Right to Buy) | |
| Shattuck Labs Inc | Arundathy Nirmalini Pandite | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 69,750 | 69,750 | - | - | Stock Option (Right to Buy) | |
| Eloxx Pharma | Sumit Aggarwal | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 68,700 | 68,700 | - | - | Stock Options (Right to Buy) | |
| Yelp Inc | David A. Schwarzbach | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 68,334 | 241,619 (0%) | 0% | 0 | Common Stock | |
| Yelp Inc | Sam Eaton | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 68,334 | 249,060 (0%) | 0% | 0 | Common Stock | |
| Alcoa Corp | Jeffrey D. Heeter | EVP & Gen. Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 65,870 | 120,378 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Alcoa Corp | John D. Slaven | EVP & Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 65,870 | 110,816 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| APA | D. Clay Bretches | Exec. VP, Operations | 25 Jan 2023 | 65,162 | 151,533 | - | - | Restricted Stock / Units | ||
| Evolus Inc | Sandra Beaver | Chief Financial Officer | 25 Jan 2023 | 62,642 | 99,085 (0%) | 0% | 0 | Common Stock | ||
| Alcoa Corp | Roy Christopher Harvey | Director, President, CEO & Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 61,320 | 679,471 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Achieve Life Sciences Inc | Cindy Jacobs | Director, President & CMO | 25 Jan 2023 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | ||
| Achieve Life Sciences Inc | Cindy Jacobs | Director, President & CMO | 25 Jan 2023 | 60,000 | 60,000 | - | - | Performance Restricted Stock Unit (PRSU) | ||
| Marchex Inc (Class B) | Michael A. Arends | Co-CEO | 25 Jan 2023 | 59,000 | 59,000 | - | - | Employee Stock Option (right to buy) | ||
| Marchex Inc (Class B) | Michael A. Arends | Co-CEO | 25 Jan 2023 | 59,000 | 1,402,129 (3%) | 0% | 0.0 | 590 | Class B Common Stock | |
| Pliant Therapeutics Inc | Eric Lefebvre | Chief Medical Officer | 25 Jan 2023 | 57,000 | 133,926 | - | 0 | Common Stock | ||
| FTC Solar Inc | Tamara Mullings | Director | 25 Jan 2023 | 56,537 | 223,118 | - | 0 | Common Stock | ||
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | 25 Jan 2023 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | ||
| Shattuck Labs Inc | Casi DeYoung | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 54,200 | 54,200 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Hans P. Hull | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 54,000 | 192,191 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Keith Cummings | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 54,000 | 138,424 | - | 0 | Common Stock | |
| Axe Compute Inc | Charles Lee Nuzum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 53,539 | 579,704 (14%) | 1% | 0 | Common Stock | |
| Patrick Ind Inc | Andy L. Nemeth | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 52,941 | 336,479 (1%) | 0% | 0 | Common Stock | |
| Shattuck Labs Inc | Abhinav A. Shukla | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 52,200 | 52,200 | - | - | Stock Option (Right to Buy) | |
| APA | Rebecca A. Hoyt | Sr. VP, Chief Acct Officer | 25 Jan 2023 | 51,585 | 96,135 | - | - | Restricted Stock / Units | ||
| Ball Corp | Daniel W. Fisher | Director, President & C.E.O. | 25 Jan 2023 | 51,201 | 98,127 | - | - | Restricted Stock Units | ||
| Marchex Inc (Class B) | Russell C. Horowitz | Director, Executive Chairman, Ten Percent Owner, Co-CEO | Grant, award, or other acquisition of securities at price $ 0.01 per share. | 25 Jan 2023 | 51,000 | 976,918 (2%) | 0% | 0.0 | 510 | Class B Common Stock |
| Marchex Inc (Class B) | Russell C. Horowitz | Director, Executive Chairman, Ten Percent Owner, Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 51,000 | 51,000 | - | - | Employee Stock Option (right to buy) | |
| APA | Mark D Maddox | Executive VP - Administration | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 50,682 | 104,451 | - | - | Restricted Stock / Units | |
| Bank of America | Lauren A. Mogensen | Global General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 50,000 | 0 | - | - | Restricted Stock Units | |
| Bank of America | Lauren A. Mogensen | Global General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 50,000 | 384,857 (0%) | 0% | - | Common Stock | |
| Bank of America | Darrin Steve Boland | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 50,000 | 0 | - | - | Restricted Stock Units | |
| Bank of America | Darrin Steve Boland | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 50,000 | 98,091 (0%) | 0% | - | Common Stock | |
| Bank of America | Thomas M. Scrivener | Chief Operations Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 50,000 | 103,343 (0%) | 0% | - | Common Stock | |
| Bank of America | Thomas M. Scrivener | Chief Operations Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 50,000 | 0 | - | - | Restricted Stock Units | |
| Bank of America | Aditya Bhasin | Chief Tech & Info Officer | 25 Jan 2023 | 50,000 | 117,101 (0%) | 0% | - | Common Stock | ||
| Bank of America | Aditya Bhasin | Chief Tech & Info Officer | 25 Jan 2023 | 50,000 | 0 | - | - | Restricted Stock Units | ||
| Marchex Inc (Class B) | Ryan Polley | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.01 per share. | 25 Jan 2023 | 50,000 | 245,000 (0%) | 0% | 0.0 | 500 | Class B Common Stock |
| Yelp Inc | Jeremy Stoppelman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.18 per share. | 25 Jan 2023 | 50,000 | 693,403 (0%) | 0% | 21.2 | 1,059,000 | Common Stock |
| Yelp Inc | Jeremy Stoppelman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 50,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Yelp Inc | Jeremy Stoppelman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 30.46 per share. | 25 Jan 2023 | 50,000 | 643,403 (0%) | 0% | 30.5 | 1,522,765 | Common Stock |
| Yelp Inc | Craig Saldanha | Chief Product Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 50,000 | 165,042 (0%) | 0% | 0 | Common Stock | |
| Biomarin pharma Inc - Registered Shares | Jeffrey R. Ajer | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 67.81 per share. | 25 Jan 2023 | 49,000 | 90,088 (0%) | 0% | 67.8 | 3,322,690 | Common Stock |
| APA | David A. Pursell | Exec. Vice Pres - Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 48,872 | 133,401 | - | - | Restricted Stock / Units | |
| APA | David A. Pursell | Exec. Vice Pres - Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 48,872 | 119,505 (0%) | 0% | 0 | Common Stock | |
| APA | David A. Pursell | Exec. Vice Pres - Development | Sale or transfer of securities back to the company at price $ 46.68 per share. | 25 Jan 2023 | 48,872 | 70,633 (0%) | 0% | 46.7 | 2,281,345 | Common Stock |
| Shattuck Labs Inc | Erin Ator Thomson | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 48,250 | 48,250 | - | - | Stock Option (Right to Buy) | |
| Ball Corp | John A. Hayes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 47,198 | 47,198 | - | - | Stock Option (Right to Buy) | |
| Applied Dna Sciences Inc | Yacov A. Shamash | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 46,938 | 46,938 | - | - | Non-Qualified Stock Option (right to buy) | |
| Biomarin pharma Inc - Registered Shares | Jeffrey R. Ajer | EVP, Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 46,800 | 0 | - | - | Stock Option (Right to buy Common Stock) | |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 190.18 per share. | 25 Jan 2023 | 46,086 | 2,776,316 (4%) | 0% | 190.2 | 8,764,465 | Common Stock |
| APA | P. Anthony Lannie | Exec. Vice Pres & Gen Counsel | 25 Jan 2023 | 45,286 | 71,072 (0%) | 0% | 46.7 | 2,113,950 | Common Stock | |
| APA | P. Anthony Lannie | Exec. Vice Pres & Gen Counsel | 25 Jan 2023 | 45,286 | 116,358 (0%) | 0% | 0 | Common Stock | ||
| APA | P. Anthony Lannie | Exec. Vice Pres & Gen Counsel | 25 Jan 2023 | 45,286 | 118,855 | - | - | Restricted Stock / Units | ||
| Biomarin pharma Inc - Registered Shares | Jeffrey R. Ajer | EVP, Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 115.65 per share. | 25 Jan 2023 | 44,825 | 45,263 (0%) | 0% | 115.7 | 5,184,191 | Common Stock |
| Archer-Daniels-Midland | Jennifer L. Weber | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 44,684 | 118,356 (0%) | 0% | 0 | Common Stock | |
| Enveric Biosciences Inc | Joseph Tucker | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 44,000 | 74,196 (2%) | 1% | 0 | Common Stock | |
| Lucky Strike Entertainment Corp (Class A) | Thomas F. Shannon | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 14.29 per share. | 25 Jan 2023 | 43,347 | 1,112,815 | - | 14.3 | 619,429 | Class A Common Stock |
| Yelp Inc | Carmen Orr | Chief People Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 43,334 | 114,115 (0%) | 0% | 0 | Common Stock | |
| Alcoa Corp | William F. Oplinger | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.19 per share. | 25 Jan 2023 | 42,923 | 196,197 (0%) | 0% | 52.2 | 2,240,151 | Common Stock, par value $0.01 per share |
| United Rentals | Matthew J. Flannery | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 392.48 per share. | 25 Jan 2023 | 42,848 | 129,812 (0%) | 0% | 392.5 | 16,816,983 | Common Stock |
| Ball Corp | Scott C. Morrison | E.V.P. and C.F.O. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 42,596 | 42,596 | - | - | Stock Option (Right to Buy) | |
| Owlet Inc (Class A) | Laura J. Durr | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 42,492 | 42,492 | - | - | Restricted Stock Units | |
| Owlet Inc (Class A) | Zane M. Burke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 42,492 | 42,492 | - | - | Restricted Stock Units | |
| Owlet Inc (Class A) | John C. Kim | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 42,492 | 42,492 | - | - | Restricted Stock Units | |
| Bank of America | James P. DeMare | President, Global Markets | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.87 per share. | 25 Jan 2023 | 41,318 | 174,489 (0%) | 0% | 34.9 | 1,440,759 | Common Stock |
| Applied Dna Sciences Inc | Joseph D. Ceccoli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 41,305 | 41,305 | - | - | Non-Qualified Stock Option (right to buy) | |
| Bank of America | Alastair Borthwick | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.87 per share. | 25 Jan 2023 | 41,171 | 260,057 (0%) | 0% | 34.9 | 1,435,633 | Common Stock |
| Matson Inc | Matthew J. Cox | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.94 per share. | 25 Jan 2023 | 40,819 | 292,454 (0%) | 0% | 62.9 | 2,569,148 | Common Stock |
| Applied Dna Sciences Inc | Elizabeth M. Schmalz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 40,366 | 40,366 | - | - | Non-Qualified Stock Option (right to buy) | |
| Fortune Brands Innovations Inc | Nicholas I. Fink | Director, Chief Executive Officer | 25 Jan 2023 | 40,273 | 264,176 (0%) | 0% | 62.7 | 2,526,325 | Common Stock, Par Value $0.01 | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 25 Jan 2023 | 40,000 | 5,451,946 (1%) | 0% | 1.0 | 39,600 | Common Stock |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 40,000 | 1,707,155 | - | - | Stock Option (Right to Buy) | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 40,000 | 1,747,155 | - | - | Stock Option (Right to Buy) | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.99 per share. | 25 Jan 2023 | 40,000 | 5,451,946 (1%) | 0% | 1.0 | 39,600 | Common Stock |
| Applied Dna Sciences Inc | Robert B. Catell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 39,428 | 39,428 | - | - | Non-Qualified Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | 25 Jan 2023 | 39,000 | 44,947 | - | 0 | Common Stock | ||
| Ball Corp | Ronald J. Lewis | SR VP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 38,938 | 38,938 | - | - | Stock Option (Right to Buy) | |
| Applied Dna Sciences Inc | Sanford R. Simon | Director | 25 Jan 2023 | 38,489 | 38,489 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 191.25 per share. | 25 Jan 2023 | 38,257 | 2,712,391 (4%) | 0% | 191.3 | 7,316,670 | Common Stock |
| Bank of America | Andrew M. Sieg | Pres, Merrill Wealth Mgmt | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.87 per share. | 25 Jan 2023 | 38,174 | 350,712 (0%) | 0% | 34.9 | 1,331,127 | Common Stock |
| Shattuck Labs Inc | Arundathy Nirmalini Pandite | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 37,875 | 175,792 | - | 0 | Common Stock | |
| Bone Biologics Corp | Jeffrey Frelick | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 37,750 | 140,140 | - | - | Employee Stock Option | |
| Applied Dna Sciences Inc | Scott L. Anchin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 37,550 | 37,550 | - | - | Non-Qualified Stock Option (right to buy) | |
| Dave Inc (Class A) | Kyle Beilman | CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 37,539 | 198,526 | - | 0 | Class A Common Stock | |
| Albertsons Companies Inc (Class A) | Mohammad Omer Gajial | EVP, Health & Chief Dig Office | 25 Jan 2023 | 36,000 | 20,042 | - | 21.1 | 757,800 | Class A common stock, par value $0.01 | |
| Albertsons Companies Inc (Class A) | Mohammad Omer Gajial | EVP, Health & Chief Dig Office | 25 Jan 2023 | 36,000 | 18,356 | - | 21.1 | 757,800 | Class A common stock, par value $0.01 | |
| Shattuck Labs Inc | Andrew R. Neill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 34,925 | 144,416 | - | 0 | Common Stock | |
| Alphabet (Class A) | John Kent Walker | President, Global Affairs, CLO | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Jan 2023 | 34,801 | 0 (0%) | 0% | 0 | Class C Capital Stock | |
| Alphabet (Class A) | John Kent Walker | President, Global Affairs, CLO | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Jan 2023 | 34,801 | 76,771 (0%) | 0% | 0 | Class C Capital Stock | |
| FirstCash Holdings Inc | Douglas R. Rippel | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 90.10 per share. | 25 Jan 2023 | 33,516 | 7,141,044 (17%) | 0% | 90.1 | 3,019,792 | Common Stock |
| APA | D. Clay Bretches | Exec. VP, Operations | 25 Jan 2023 | 32,581 | 35,344 (0%) | 0% | 46.7 | 1,520,881 | Common Stock | |
| APA | D. Clay Bretches | Exec. VP, Operations | 25 Jan 2023 | 32,581 | 118,952 | - | - | Restricted Stock / Units | ||
| APA | D. Clay Bretches | Exec. VP, Operations | 25 Jan 2023 | 32,581 | 67,897 (0%) | 0% | 0 | Common Stock | ||
| Block Inc (Class A) | Alyssa Henry | Square Lead | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 30,769 | 430,766 | - | - | Stock Option (right to buy) | |
| Block Inc (Class A) | Alyssa Henry | Square Lead | 25 Jan 2023 | 30,769 | 0 | - | - | Class B Common Stock | ||
| Block Inc (Class A) | Alyssa Henry | Square Lead | 25 Jan 2023 | 30,769 | 449,436 (0%) | 0% | 0 | Class A Common Stock | ||
| Block Inc (Class A) | Alyssa Henry | Square Lead | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 30,769 | 30,769 | - | - | Class B Common Stock | |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 190.26 per share. | 25 Jan 2023 | 30,644 | 2,750,648 (4%) | 0% | 190.3 | 5,830,438 | Common Stock |
| Chevron | Mark A. Nelson | Vice Chairman and EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 30,100 | 30,100 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Chevron | Andrew Nigel Hearne | Executive Vice President | 25 Jan 2023 | 30,100 | 30,100 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| Dave Inc (Class A) | Kyle Beilman | CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 30,031 | 160,987 | - | 0 | Class A Common Stock | |
| Albertsons Companies Inc (Class A) | Robert B. Larson | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 21.01 per share. | 25 Jan 2023 | 30,000 | 50,241 | - | 21.0 | 630,300 | Class A common stock, par value $0.01 |
| Oppenheimer Holdings Inc (Class A) | Albert G. Lowenthal | Director, CEO, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 25 Jan 2023 | 30,000 | 30,000 | - | - | Restricted Class A non-voting common stock | |
| Eloxx Pharma | Vijay Modur | HEAD OF R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 30,000 | 30,000 | - | - | Stock Options (Right to Buy) | |
| WisdomTree Inc | Peter M. Ziemba | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 29,372 | 29,372 | - | - | Performance Based Restricted Stock Units | |
| SPS Commerce Inc | James J. Frome | President & COO | 25 Jan 2023 | 28,834 | 64,218 (0%) | 0% | 0 | Common Stock | ||
| SPS Commerce Inc | Kimberly K. Nelson | EVP & CFO | 25 Jan 2023 | 28,834 | 155,222 (0%) | 0% | 0 | Common Stock | ||
| Archrock Inc | D. Bradley Childers | Director, PRESIDENT AND CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Jan 2023 | 28,000 | 1,841,284 (1%) | 0% | 0 | Common Stock | |
| Ball Corp | Charles E. Baker | VP, GEN COUNSEL & CORP SEC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 27,729 | 27,729 | - | - | Stock Option (Right to Buy) | |
| Shattuck Labs Inc | Casi DeYoung | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 27,100 | 46,880 | - | 0 | Common Stock | |
| Shattuck Labs Inc | Abhinav A. Shukla | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 26,100 | 47,092 | - | 0 | Common Stock | |
| Alcoa Corp | John D. Slaven | EVP & Chief Operations Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.19 per share. | 25 Jan 2023 | 25,977 | 84,839 (0%) | 0% | 52.2 | 1,355,740 | Common Stock, par value $0.01 per share |
| APA | Rebecca A. Hoyt | Sr. VP, Chief Acct Officer | 25 Jan 2023 | 25,792 | 70,343 | - | - | Restricted Stock / Units | ||
| APA | Rebecca A. Hoyt | Sr. VP, Chief Acct Officer | 25 Jan 2023 | 25,792 | 111,156 (0%) | 0% | 0 | Common Stock | ||
| APA | Rebecca A. Hoyt | Sr. VP, Chief Acct Officer | 25 Jan 2023 | 25,792 | 85,364 (0%) | 0% | 46.7 | 1,203,971 | Common Stock | |
| Alcoa Corp | Jeffrey D. Heeter | EVP & Gen. Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.19 per share. | 25 Jan 2023 | 25,740 | 94,638 (0%) | 0% | 52.2 | 1,343,371 | Common Stock, par value $0.01 per share |
| Matson Inc | Joel M. Wine | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 25,428 | 171,663 (0%) | 0% | 0 | Common Stock | |
| APA | Mark D Maddox | Executive VP - Administration | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 25,339 | 79,112 | - | - | Restricted Stock / Units | |
| APA | Mark D Maddox | Executive VP - Administration | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 25,339 | 72,810 (0%) | 0% | 0 | Common Stock | |
| APA | Mark D Maddox | Executive VP - Administration | Sale or transfer of securities back to the company at price $ 46.68 per share. | 25 Jan 2023 | 25,339 | 47,471 (0%) | 0% | 46.7 | 1,182,825 | Common Stock |
| Regions Financial | Scott M. Peters | SEVP | 25 Jan 2023 | 25,316 | 0 (0%) | 0% | 22.4 | 567,957 | Common Stock | |
| FirstCash Holdings Inc | Douglas R. Rippel | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 90.68 per share. | 25 Jan 2023 | 25,051 | 7,115,993 (16%) | 0% | 90.7 | 2,271,625 | Common Stock |
| Archrock Inc | D. Bradley Childers | Director, PRESIDENT AND CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Jan 2023 | 25,000 | 1,869,284 (1%) | 0% | 0 | Common Stock | |
| Applied Digital Corp | Wesley Cummins | Director, CEO; Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.48 per share. | 25 Jan 2023 | 25,000 | 1,770,686 | - | 2.5 | 62,000 | Common Stock |
| SkyAI Inc | Andrew R. Crescenzo | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Jan 2023 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| CVB Fin Corp | David Brager | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 24,814 | 128,464 (0%) | 0% | 0 | Common Stock | |
| Shattuck Labs Inc | Erin Ator Thomson | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 24,125 | 103,209 | - | 0 | Common Stock | |
| Herc Holdings Inc | Carl C. Icahn | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 144.44 per share. | 25 Jan 2023 | 24,083 | 3,446,749 (11%) | 0% | 144.4 | 3,478,549 | Common Stock, par value $0.01 per share ("Shares") |
| Matson Inc | Matthew J. Cox | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 23,833 | 333,273 (0%) | 0% | 0 | Common Stock | |
| Chevron | Michael K. Wirth | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 23,730 | 23,730 (0%) | 0% | 0 | Common Stock | |
| Alcoa Corp | Molly S. Beerman | Senior VP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 23,066 | 62,195 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Alcoa Corp | Benjamin D. Kahrs | EVP & Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 23,066 | 41,825 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Alcoa Corp | Renato Bacchi | EVP & Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 23,066 | 76,694 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Chevron | Pierre R. Breber | VP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 23,000 | 23,000 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Chevron | R Hewitt Pate | VP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 23,000 | 23,000 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Chevron | R Hewitt Pate | VP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 23,000 | 23,000 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Herc Holdings Inc | Carl C. Icahn | Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 153.85 per share. | 25 Jan 2023 | 22,729 | 3,335,204 (11%) | 0% | 153.9 | 3,496,857 | Shares |
| Patrick Ind Inc | Jeffrey M. Rodino | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 22,500 | 158,183 (0%) | 0% | 0 | Common Stock | |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 189.24 per share. | 25 Jan 2023 | 22,326 | 2,822,402 (4%) | 0% | 189.2 | 4,224,941 | Common Stock |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 192.16 per share. | 25 Jan 2023 | 22,306 | 2,689,808 (4%) | 0% | 192.2 | 4,286,227 | Common Stock |
| Bank of America | Lauren A. Mogensen | Global General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.87 per share. | 25 Jan 2023 | 22,304 | 362,553 (0%) | 0% | 34.9 | 777,740 | Common Stock |
| Matson Inc | Peter T. Heilmann | EVP, Chief Admin. Officer & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 22,250 | 62,204 (0%) | 0% | 0 | Common Stock | |
| Matson Inc | John P. Lauer | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 22,250 | 54,410 (0%) | 0% | 0 | Common Stock | |
| Bank of America | Aditya Bhasin | Chief Tech & Info Officer | 25 Jan 2023 | 22,222 | 94,879 (0%) | 0% | 34.9 | 774,881 | Common Stock | |
| Bank of America | Thomas M. Scrivener | Chief Operations Executive | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.87 per share. | 25 Jan 2023 | 22,195 | 81,148 (0%) | 0% | 34.9 | 773,940 | Common Stock |
| Archer-Daniels-Midland | Vikram Luthar | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 22,136 | 94,438 (0%) | 0% | 0 | Common Stock | |
| Bank of America | Darrin Steve Boland | Chief Administrative Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.87 per share. | 25 Jan 2023 | 22,096 | 75,995 (0%) | 0% | 34.9 | 770,488 | Common Stock |
| WisdomTree Inc | Alexis Marinof | Head of Europe | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 22,013 | 22,013 | - | - | Performance Based Restricted Stock Units | |
| FirstCash Holdings Inc | Douglas R. Rippel | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 90.81 per share. | 25 Jan 2023 | 21,255 | 7,094,738 (16%) | 0% | 90.8 | 1,930,167 | Common Stock |
| WisdomTree Inc | Bryan J. Edmiston | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 21,186 | 21,186 | - | - | Performance Based Restricted Stock Units | |
| WisdomTree Inc | Marci Frankenthaler | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 21,186 | 21,186 | - | - | Performance Based Restricted Stock Units | |
| Axogen Inc | Peter J. Mariani | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.16 per share. | 25 Jan 2023 | 20,940 | 42,108 (0%) | 0% | 10.2 | 212,750 | Common Stock |
| Axogen Inc | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 20,940 | 62,818 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 25 Jan 2023 | 20,940 | 63,048 (0%) | 0% | 5.0 | 105,538 | Common Stock |
| Axogen Inc | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 20,939 | 83,758 | - | - | Employee Stock Option (right to purchase) | |
| Axogen Inc | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 25 Jan 2023 | 20,939 | 63,047 (0%) | 0% | 5.0 | 105,533 | Common Stock |
| Axogen Inc | Peter J. Mariani | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 10.23 per share. | 25 Jan 2023 | 20,939 | 42,108 (0%) | 0% | 10.2 | 214,206 | Common Stock |
| Axogen Inc | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.04 per share. | 25 Jan 2023 | 20,939 | 63,047 (0%) | 0% | 5.0 | 105,533 | Common Stock |
| Axogen Inc | Peter J. Mariani | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.90 per share. | 25 Jan 2023 | 20,939 | 42,108 (0%) | 0% | 9.9 | 207,296 | Common Stock |
| Axogen Inc | Peter J. Mariani | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 20,939 | 104,697 | - | - | Employee Stock Option (right to purchase) | |
| Regions Financial | Scott M. Peters | SEVP | 25 Jan 2023 | 20,263 | 18,704 | - | - | Phantom Stock Units | ||
| Ball Corp | Stacey Valy Panayiotou | SVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 20,248 | 20,248 | - | - | Stock Option (Right to Buy) | |
| Oppenheimer Holdings Inc (Class A) | Robert S Lowenthal | Director | Other type of transaction at price $ 0.00 per share. | 25 Jan 2023 | 20,000 | 20,000 | - | - | Restricted Class A non-voting common stock | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 192.32 per share. | 25 Jan 2023 | 19,850 | 5,419,046 (1%) | 0% | 192.3 | 3,817,552 | Common Stock |
| Patrick Ind Inc | Kip B. Ellis | EVP Operations & COO | 25 Jan 2023 | 19,413 | 130,145 (0%) | 0% | 0 | Common Stock | ||
| WisdomTree Inc | William Bradley Peck | Head of Digital Assets | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 19,260 | 19,260 | - | - | Performance Based Restricted Stock Units | |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 192.41 per share. | 25 Jan 2023 | 19,228 | 2,599,509 (4%) | 0% | 192.4 | 3,699,704 | Common Stock |
| Bone Biologics Corp | Deina H. Walsh | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 18,875 | 43,875 | - | - | Employee Stock Option | |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 189.38 per share. | 25 Jan 2023 | 18,833 | 2,648,460 (4%) | 0% | 189.4 | 3,566,545 | Common Stock |
| Patrick Ind Inc | Jacob R. Petkovich | EVP Finance, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 18,531 | 80,531 (0%) | 0% | 0 | Common Stock | |
| WisdomTree Inc | David M. Yates | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 18,297 | 18,297 | - | - | Performance Based Restricted Stock Units | |
| United Rentals | Matthew J. Flannery | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 392.48 per share. | 25 Jan 2023 | 18,157 | 111,655 (0%) | 0% | 392.5 | 7,126,259 | Common Stock |
| Block Inc (Class A) | Alyssa Henry | Square Lead | Sale of securities on an exchange or to another person at price $ 76.95 per share. | 25 Jan 2023 | 18,149 | 431,287 (0%) | 0% | 77.0 | 1,396,566 | Class A Common Stock |
| Bank of America | Rudolf A. Bless | Chief Accounting Officer | 25 Jan 2023 | 18,000 | 176,754 (0%) | 0% | - | Common Stock | ||
| Bank of America | Rudolf A. Bless | Chief Accounting Officer | 25 Jan 2023 | 18,000 | 18,000 | - | - | Restricted Stock Units | ||
| CF Bankshares Inc | Timothy T. O'Dell | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 17,715 | 277,328 (5%) | 0% | 0 | Common Stock 12520L 109 | |
| Chevron | Eimear P. Bonner | Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 17,400 | 17,400 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| LSB Ind Inc | Cheryl Maguire | EVP/CFO | Grant, award, or other acquisition of securities at price $ 12.34 per share. | 25 Jan 2023 | 17,261 | 291,369 (0%) | 0% | 12.3 | 213,001 | Common Stock |
| LSB Ind Inc | Michael J. Foster | EVP/General Counsel/Sec | Grant, award, or other acquisition of securities at price $ 12.34 per share. | 25 Jan 2023 | 17,099 | 434,535 (1%) | 0% | 12.3 | 211,002 | Common Stock |
| Enveric Biosciences Inc | Peter Facchini | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 17,000 | 40,865 (1%) | 0% | 0 | Common Stock | |
| Chewy Inc (Class A) | Susan Helfrick | General Counsel | Sale of securities on an exchange or to another person at price $ 45.00 per share. | 25 Jan 2023 | 16,947 | 56,270 (0%) | 0% | 45 | 762,615 | Class A Common Stock |
| Coastal Fin Corp | Sprink M Eric | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 16,731 | 285,519 (2%) | 0% | 0 | Common Stock | |
| Alcoa Corp | Jeffrey D. Heeter | EVP & Gen. Counsel | Sale of securities on an exchange or to another person at price $ 51.95 per share. | 25 Jan 2023 | 16,668 | 77,970 (0%) | 0% | 51.9 | 865,843 | Common Stock, par value $0.01 per share |
| Ball Corp | David A. Kaufman | President, Ball Aerospace | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 16,519 | 16,519 | - | - | Stock Option (Right to Buy) | |
| Bakkt Holdings Inc (Class A) | Mark Sonbolian Elliot | Chief Sales & Mktg Officer | Sale of securities on an exchange or to another person at price $ 1.69 per share. | 25 Jan 2023 | 16,500 | 303,914 | - | 1.7 | 27,949 | Class A Common Stock |
| BGC Grp Inc (Class A) | Martin Laguerre | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 16,355 | 16,355 (0%) | 0% | 0 | Class A Common Stock, par value $0.01 per share | |
| Arteris Inc | K. Charles Janac | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Jan 2023 | 16,200 | 10,307,691 | - | 0 | Common Stock | |
| Matson Inc | Vicente S. Angoco | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 15,893 | 56,323 (0%) | 0% | 0 | Common Stock | |
| Matson Inc | Rusty K. Rolfe | EVP, President of Matson Logistics | 25 Jan 2023 | 15,893 | 35,220 (0%) | 0% | 0 | Common Stock | ||
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 191.08 per share. | 25 Jan 2023 | 15,847 | 5,419,146 (1%) | 0% | 191.1 | 3,028,045 | Common Stock |
| Bankwell Fin Grp Inc | Christopher R. Gruseke | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 15,543 | 15,543 (0%) | 0% | 0 | Common Stock | |
| Archrock Inc | Stephanie Hildebrandt | SVP, GENERAL COUNSEL | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.38 per share. | 25 Jan 2023 | 15,506 | 269,391 (0%) | 0% | 9.4 | 145,446 | Common Stock |
| Heico Corp (Class A) | Alan Schriesheim | Director | Sale of securities on an exchange or to another person at price $ 167.33 per share. | 25 Jan 2023 | 15,000 | 115,331 (0%) | 0% | 167.3 | 2,509,913 | Common Stock |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Achieve Life Sciences Inc | Jerry Wan | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 15,000 | 15,000 | - | - | Performance Restricted Stock Unit (PRSU) | |
| Pliant Therapeutics Inc | Bernard Coulie | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 25 Jan 2023 | 15,000 | 255,112 | - | 2.1 | 31,200 | Common Stock |
| Pliant Therapeutics Inc | Bernard Coulie | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 35.29 per share. | 25 Jan 2023 | 15,000 | 240,112 | - | 35.3 | 529,367 | Common Stock |
| Pliant Therapeutics Inc | Bernard Coulie | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 35.10 per share. | 25 Jan 2023 | 15,000 | 419,317 | - | 35.1 | 526,425 | Common Stock |
| Pliant Therapeutics Inc | Bernard Coulie | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.08 per share. | 25 Jan 2023 | 15,000 | 255,112 | - | 2.1 | 31,200 | Common Stock |
| Pliant Therapeutics Inc | Bernard Coulie | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 15,000 | 187,380 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Bernard Coulie | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 15,000 | 172,380 | - | - | Stock Option (right to buy) | |
| Yelp Inc | Jeremy Stoppelman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.18 per share. | 25 Jan 2023 | 15,000 | 658,403 (0%) | 0% | 21.2 | 317,700 | Common Stock |
| Yelp Inc | Jeremy Stoppelman | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 15,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Yelp Inc | Jeremy Stoppelman | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 31.12 per share. | 25 Jan 2023 | 15,000 | 643,403 (0%) | 0% | 31.1 | 466,782 | Common Stock |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 189.46 per share. | 25 Jan 2023 | 14,919 | 2,781,292 (4%) | 0% | 189.5 | 2,826,491 | Common Stock |
| Archrock Inc | Douglas S. Aron | SR VICE PRESIDENT, CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.38 per share. | 25 Jan 2023 | 14,697 | 393,862 (0%) | 0% | 9.4 | 137,858 | Common Stock |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 191.94 per share. | 25 Jan 2023 | 14,242 | 2,623,104 (4%) | 0% | 191.9 | 2,733,647 | Common Stock |
| Ball Corp | John A. Hayes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 14,124 | 131,865 | - | - | Restricted Stock Units | |
| Allbirds Inc (Class A) | Joseph Zwillinger | Director, Co-Chief Executive Officer, Ten Percent Owner | 25 Jan 2023 | 13,867 | 11,084,143 | - | - | Class B Common Stock | ||
| Allbirds Inc (Class A) | Joseph Zwillinger | Director, Co-Chief Executive Officer, Ten Percent Owner | 25 Jan 2023 | 13,867 | 0 | - | 2.8 | 38,550 | Class A Common Stock | |
| Allbirds Inc (Class A) | Joseph Zwillinger | Director, Co-Chief Executive Officer, Ten Percent Owner | 25 Jan 2023 | 13,867 | 13,867 | - | 0 | Class A Common Stock | ||
| Alcoa Corp | William F. Oplinger | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 13,800 | 130,285 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Alcoa Corp | Molly S. Beerman | Senior VP & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 13,800 | 39,129 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| United Rentals | Dale A Asplund | EVP, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 436.26 per share. | 25 Jan 2023 | 13,392 | 19,229 (0%) | 0% | 436.3 | 5,842,415 | Common Stock |
| Montrose Environmental Grp Inc | Richard E. Perlman | Director | Sale of securities on an exchange or to another person at price $ 52.87 per share. | 25 Jan 2023 | 12,853 | 835,691 | - | 52.9 | 679,538 | Common Stock |
| Ball Corp | Scott C. Morrison | E.V.P. and C.F.O. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 12,747 | 38,916 | - | - | Restricted Stock Units | |
| Block Inc (Class A) | Alyssa Henry | Square Lead | Sale of securities on an exchange or to another person at price $ 77.79 per share. | 25 Jan 2023 | 12,620 | 418,667 (0%) | 0% | 77.8 | 981,710 | Class A Common Stock |
| Matson Inc | Joel M. Wine | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.94 per share. | 25 Jan 2023 | 12,607 | 166,206 (0%) | 0% | 62.9 | 793,485 | Common Stock |
| Fortune Brands Innovations Inc | Patrick D. Hallinan | EVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.73 per share. | 25 Jan 2023 | 12,460 | 66,634 (0%) | 0% | 62.7 | 781,616 | Common Stock, Par Value $0.01 |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 12,429 | 530,488 | - | - | Employee Stock Option | |
| CVB Fin Corp | Yamynn DeAngelis | EVP Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 12,400 | 116,126 (0%) | 0% | 0 | Common Stock | |
| United Rentals | Dale A Asplund | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 392.48 per share. | 25 Jan 2023 | 12,264 | 37,461 (0%) | 0% | 392.5 | 4,813,375 | Common Stock |
| Chevron | Rhonda J. Morris | Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 12,200 | 12,200 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 188.35 per share. | 25 Jan 2023 | 12,106 | 2,796,211 (4%) | 0% | 188.4 | 2,280,170 | Common Stock |
| Enveric Biosciences Inc | Jill Hagel | Vice President of Innovation | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 12,000 | 35,802 (1%) | 0% | 0 | Common Stock | |
| SmartFinancial Inc | William Y. Carroll | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 11,873 | 111,972 (0%) | 0% | 0 | Common Stock | |
| Archrock Inc | Jason G. Ingersoll | SENIOR VICE PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.38 per share. | 25 Jan 2023 | 11,846 | 220,594 (0%) | 0% | 9.4 | 111,115 | Common Stock |
| Delta Air Lines | Alain Bellemare | EVP & Pres. - International | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.38 per share. | 25 Jan 2023 | 11,766 | 124,077 (0%) | 0% | 39.4 | 463,345 | Common Stock |
| Ball Corp | Ronald J. Lewis | SR VP & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 11,653 | 35,982 | - | - | Restricted Stock Units | |
| Mayville Engineering Co Inc | Sean P Leuba | SVP, Corp. Development & GC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 11,566 | 11,566 | - | - | Restricted Stock Units | |
| LSB Ind Inc | P. | Executive Vice President-Mfg | Grant, award, or other acquisition of securities at price $ 12.34 per share. | 25 Jan 2023 | 11,508 | 207,243 (0%) | 0% | 12.3 | 142,009 | Common Stock |
| LSB Ind Inc | J. | EVP/Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 12.34 per share. | 25 Jan 2023 | 11,508 | 88,424 (0%) | 0% | 12.3 | 142,009 | Common Stock |
| Bankwell Fin Grp Inc | Matt McNeill | EVP & Chief Banking Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 11,185 | 11,185 (0%) | 0% | 0 | Common Stock | |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 190.81 per share. | 25 Jan 2023 | 11,114 | 2,637,346 (4%) | 0% | 190.8 | 2,120,647 | Common Stock |
| Ventas | Robert F. Probst | EVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.81 per share. | 25 Jan 2023 | 11,095 | 173,477 (0%) | 0% | 50.8 | 563,737 | Common Stock |
| Matson Inc | Peter T. Heilmann | EVP, Chief Admin. Officer & GC | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.94 per share. | 25 Jan 2023 | 11,031 | 56,734 (0%) | 0% | 62.9 | 694,291 | Common Stock |
| Matson Inc | John P. Lauer | EVP & Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.94 per share. | 25 Jan 2023 | 11,031 | 48,940 (0%) | 0% | 62.9 | 694,291 | Common Stock |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 187.20 per share. | 25 Jan 2023 | 11,021 | 2,808,317 (4%) | 0% | 187.2 | 2,063,101 | Common Stock |
| Archrock Inc | Eric W. Thode | SR VICE PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.38 per share. | 25 Jan 2023 | 10,884 | 137,417 (0%) | 0% | 9.4 | 102,092 | Common Stock |
| Grand Canyon Education Inc | Brian E. Mueller | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 10,732 | 309,984 (0%) | 0% | 0 | Common Stock | |
| United Rentals | Craig A. Pintoff | EVP, Chief Admin. Officer | Grant, award, or other acquisition of securities at price $ 392.48 per share. | 25 Jan 2023 | 10,686 | 26,628 (0%) | 0% | 392.5 | 4,194,041 | Common Stock |
| Fortune Brands Innovations Inc | Cheri M. Phyfer | EVP, Group President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.73 per share. | 25 Jan 2023 | 10,350 | 77,335 (0%) | 0% | 62.7 | 649,256 | Common Stock, Par Value $0.01 |
| CVB Fin Corp | Harvey C David | EVP Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 10,339 | 92,042 (0%) | 0% | 0 | Common Stock | |
| CVB Fin Corp | E. Allen Nicholson | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 10,339 | 82,074 (0%) | 0% | 0 | Common Stock | |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 187.54 per share. | 25 Jan 2023 | 10,026 | 2,676,748 (4%) | 0% | 187.5 | 1,880,291 | Common Stock |
| Enveric Biosciences Inc | Avani Kanubaddi | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 10,000 | 48,346 (1%) | 0% | 0 | Common Stock | |
| Moderna | Noubar B. Afeyan | Director | Sale of securities on an exchange or to another person at price $ 194.33 per share. | 25 Jan 2023 | 10,000 | 2,237,209 (0%) | 0% | 194.3 | 1,943,300 | Common Stock |
| Vertex Pharma | Reshma Kewalramani | Director, CEO & President | Sale of securities on an exchange or to another person at price $ 315.05 per share. | 25 Jan 2023 | 10,000 | 89,598 (0%) | 0% | 315.1 | 3,150,500 | Common Stock |
| Pliant Therapeutics Inc | Bernard Coulie | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 35.09 per share. | 25 Jan 2023 | 9,779 | 409,538 | - | 35.1 | 343,158 | Common Stock |
| Bank of America | Matthew M. Koder | Pres, Gl Corp & Invest Banking | Payment of exercise price or tax liability using portion of securities received from the company at price $ 34.87 per share. | 25 Jan 2023 | 9,710 | 429,492 (0%) | 0% | 34.9 | 338,588 | Common Stock |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 188.73 per share. | 25 Jan 2023 | 9,455 | 2,667,293 (4%) | 0% | 188.7 | 1,784,440 | Common Stock |
| NiSource | Donald E. Brown | EVP & CFO | Grant, award, or other acquisition of securities at price $ 27.58 per share. | 25 Jan 2023 | 9,355 | 173,413 (0%) | 0% | 27.6 | 258,011 | Common Stock |
| NiSource | Melody Birmingham | EVP & Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 27.58 per share. | 25 Jan 2023 | 9,355 | 56,338 (0%) | 0% | 27.6 | 258,011 | Common Stock |
| Artisan Partners Asset Management Inc (Class A) | Stephanie G. Dimarco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 9,265 | 29,418 (0%) | 0% | 0 | Class A Common Stock, par value $0.01 per share | |
| Alpha Metallurgical Resources Inc | Andrew Eidson | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 25 Jan 2023 | 9,000 | 62,900 (0%) | 0% | 0 | Common Stock, $0.01 par value per share | |
| Bank of America | Lauren A. Mogensen | Global General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 9,000 | 371,553 (0%) | 0% | - | Common Stock | |
| Bank of America | Lauren A. Mogensen | Global General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 9,000 | 9,000 | - | - | Restricted Stock Units | |
| Bank of America | Darrin Steve Boland | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 9,000 | 9,000 | - | - | Restricted Stock Units | |
| Bank of America | Darrin Steve Boland | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 9,000 | 84,995 (0%) | 0% | - | Common Stock | |
| Bank of America | Thomas M. Scrivener | Chief Operations Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 9,000 | 9,000 | - | - | Restricted Stock Units | |
| Bank of America | Thomas M. Scrivener | Chief Operations Executive | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2023 | 9,000 | 90,148 (0%) | 0% | - | Common Stock | |
| Bank of America | Aditya Bhasin | Chief Tech & Info Officer | 25 Jan 2023 | 9,000 | 103,879 (0%) | 0% | - | Common Stock | ||
| Bank of America | Aditya Bhasin | Chief Tech & Info Officer | 25 Jan 2023 | 9,000 | 9,000 | - | - | Restricted Stock Units | ||
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 191.11 per share. | 25 Jan 2023 | 8,848 | 2,767,468 (4%) | 0% | 191.1 | 1,690,981 | Common Stock |
| Patrick Ind Inc | Andy L. Nemeth | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 8,824 | 345,303 (1%) | 0% | 0 | Common Stock | |
| Patrick Ind Inc | Joel D. Duthie | Chief Legal Officer/Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 8,823 | 25,166 (0%) | 0% | 0 | Common Stock | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 190.27 per share. | 25 Jan 2023 | 8,823 | 5,434,993 (1%) | 0% | 190.3 | 1,678,752 | Common Stock |
| Chevron | David A. Inchausti | Vice Pres. and Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 8,700 | 8,700 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Chevron | Jeff B. Gustavson | Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 8,700 | 8,700 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Bernard Coulie | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 35.42 per share. | 25 Jan 2023 | 8,698 | 246,414 | - | 35.4 | 308,046 | Common Stock |
| Alpha Metallurgical Resources Inc | Andrew Eidson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 8,337 | 71,237 (0%) | 0% | 0 | Common Stock, $0.01 par value per share | |
| Crinetics Pharma Inc | Stephen F. Betz | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 21.07 per share. | 25 Jan 2023 | 8,336 | 67,815 (0%) | 0% | 21.1 | 175,640 | Common Stock |
| Ball Corp | Charles E. Baker | VP, GEN COUNSEL & CORP SEC | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 8,298 | 24,393 | - | - | Restricted Stock Units | |
| Stride Inc | Vincent W. Mathis | EVP, GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 40.65 per share. | 25 Jan 2023 | 8,160 | 44,806 (0%) | 0% | 40.7 | 331,704 | Common Stock |
| Enerpac Tool Grp Corp (Class A) | Paul E. Sternlieb | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.12 per share. | 25 Jan 2023 | 8,148 | 202,161 (0%) | 0% | 25.1 | 204,678 | Class A Common Stock |
| Bank of America | Rudolf A. Bless | Chief Accounting Officer | 25 Jan 2023 | 8,065 | 168,689 (0%) | 0% | 34.9 | 281,227 | Common Stock | |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 192.41 per share. | 25 Jan 2023 | 8,061 | 2,755,337 (4%) | 0% | 192.4 | 1,551,040 | Common Stock |
| NiSource | William Jefferson | EVP Operations & CSO | Grant, award, or other acquisition of securities at price $ 27.58 per share. | 25 Jan 2023 | 7,977 | 39,341 (0%) | 0% | 27.6 | 220,006 | Common Stock |
| Matson Inc | Rusty K. Rolfe | EVP, President of Matson Logistics | 25 Jan 2023 | 7,875 | 32,906 (0%) | 0% | 62.9 | 495,653 | Common Stock | |
| CVB Fin Corp | David F. Farnsworth | EVP & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 7,858 | 42,654 (0%) | 0% | 0 | Common Stock | |
| Ventas | Peter J. Bulgarelli | Pres&CEO-LHS/EVP Office-Ventas | Payment of exercise price or tax liability using portion of securities received from the company at price $ 50.81 per share. | 25 Jan 2023 | 7,789 | 98,941 (0%) | 0% | 50.8 | 395,759 | Common Stock |
| Chevron | Mark A. Nelson | Vice Chairman and EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 7,700 | 8,507 (0%) | 0% | 0 | Common Stock | |
| Chevron | Andrew Nigel Hearne | Executive Vice President | 25 Jan 2023 | 7,700 | 7,700 (0%) | 0% | 0 | Common Stock | ||
| Alcoa Corp | Jeffrey D. Heeter | EVP & Gen. Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 7,670 | 54,508 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Alcoa Corp | Tammi A Jones | EVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 7,670 | 42,436 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Alcoa Corp | Renato Bacchi | EVP & Chief Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 7,670 | 51,708 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Alcoa Corp | Kelly R. Thomas | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 7,670 | 13,330 (0%) | 0% | 0 | Common Stock, par value $0.01 per share | |
| Ball Corp | Nate C. Carey | Vice President & Controller | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 7,434 | 7,434 | - | - | Stock Option (Right to Buy) | |
| NiSource | Shawn Anderson | SVP Strategy & Chief Risk Off | Grant, award, or other acquisition of securities at price $ 27.58 per share. | 25 Jan 2023 | 7,342 | 59,008 (0%) | 0% | 27.6 | 202,492 | Common Stock |
| Axon | Patrick W. Smith | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 193.09 per share. | 25 Jan 2023 | 7,184 | 2,748,153 (4%) | 0% | 193.1 | 1,387,136 | Common Stock |
| Matson Inc | Joel M. Wine | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 7,150 | 178,813 (0%) | 0% | 0 | Common Stock | |
| Alcoa Corp | Benjamin D. Kahrs | EVP & Chief Innovation Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.19 per share. | 25 Jan 2023 | 7,130 | 34,695 (0%) | 0% | 52.2 | 372,115 | Common Stock, par value $0.01 per share |
| Alcoa Corp | Renato Bacchi | EVP & Chief Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.19 per share. | 25 Jan 2023 | 7,127 | 69,567 (0%) | 0% | 52.2 | 371,958 | Common Stock, par value $0.01 per share |
| Artisan Partners Asset Management Inc (Class A) | Saloni S. Multani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 7,127 | 13,080 (0%) | 0% | 0 | Class A Common Stock, par value $0.01 per share | |
| Alcoa Corp | Molly S. Beerman | Senior VP & Controller | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.19 per share. | 25 Jan 2023 | 7,126 | 55,069 (0%) | 0% | 52.2 | 371,906 | Common Stock, par value $0.01 per share |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 193.39 per share. | 25 Jan 2023 | 7,100 | 5,411,946 (1%) | 0% | 193.4 | 1,373,069 | Common Stock |
| NiSource | Melanie B. Berman | SVP & CHRO | Grant, award, or other acquisition of securities at price $ 27.58 per share. | 25 Jan 2023 | 7,097 | 13,932 (0%) | 0% | 27.6 | 195,735 | Common Stock |
| Princeton Bancorp Inc | Daniel J. O’Donnell | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 7,023 | 7,023 | - | - | Restricted Stock Units | |
| NiSource | Kimberly S. Cuccia | SVP, GC & Corp Sec | Grant, award, or other acquisition of securities at price $ 27.58 per share. | 25 Jan 2023 | 6,934 | 26,984 (0%) | 0% | 27.6 | 191,240 | Common Stock |
| Artisan Partners Asset Management Inc (Class A) | Jeffrey A. Joerres | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 6,842 | 60,455 (0%) | 0% | 0 | Class A Common Stock, par value $0.01 per share | |
| Artisan Partners Asset Management Inc (Class A) | Matthew R. Barger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 6,842 | 18,666 (0%) | 0% | 0 | Class A Common Stock, par value $0.01 per share | |
| CVB Fin Corp | Richard H. Wohl | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 6,824 | 27,585 (0%) | 0% | 0 | Common Stock | |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 190.65 per share. | 25 Jan 2023 | 6,790 | 5,445,156 (1%) | 0% | 190.7 | 1,294,514 | Common Stock |
| Pliant Therapeutics Inc | Bernard Coulie | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 36.06 per share. | 25 Jan 2023 | 6,302 | 240,112 | - | 36.1 | 227,243 | Common Stock |
| Moderna | Stephane Bancel | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 191.51 per share. | 25 Jan 2023 | 6,260 | 5,438,896 (1%) | 0% | 191.5 | 1,198,853 | Common Stock |
| Matson Inc | Vicente S. Angoco | Senior Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.94 per share. | 25 Jan 2023 | 6,249 | 54,047 (0%) | 0% | 62.9 | 393,312 | Common Stock |
| Bankwell Fin Grp Inc | Laura J. Waitz | EVP & Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 6,119 | 6,119 (0%) | 0% | 0 | Common Stock | |
| Ball Corp | Stacey Valy Panayiotou | SVP & CHRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 6,059 | 15,892 | - | - | Restricted Stock Units | |
| United Rentals | Craig A. Pintoff | EVP, Chief Admin. Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 392.48 per share. | 25 Jan 2023 | 5,925 | 20,703 (0%) | 0% | 392.5 | 2,325,444 | Common Stock |
| Chevron | Pierre R. Breber | VP & Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 5,900 | 5,908 (0%) | 0% | 0 | Common Stock | |
| Chevron | R Hewitt Pate | VP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 5,900 | 5,900 (0%) | 0% | 0 | Common Stock | |
| Chevron | R Hewitt Pate | VP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 5,900 | 5,900 (0%) | 0% | 0 | Common Stock | |
| Grand Canyon Education Inc | Daniel E. Bachus | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 5,727 | 119,395 (0%) | 0% | 0 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.